Increasing the range of minimally invasive tumour therapy

Surgery is no longer the automatic choice to eradicate malignant tumours.

Professor Thomas Vogl, Frankfurt am Main University Hospital
Professor Thomas Vogl, Frankfurt am Main University Hospital

For about a dozen years small tumours and metastases in the liver have been eliminated by heat generated at the tip of a catheter, a technique that began with liver tumours, has spread to the lung, and could be applied to breast and prostate cancers in the future.

Whether using laser beams, high-frequency electrical current or, more recently, highly-focused ultrasound – direct image monitoring is used to control such procedures.

MEDICA 2006 is presenting a range of innovations in this area.
Magnetic resonance tomography (MRT) is considered one of the ideal tools for these less invasive procedures, not only because it is radiation-free, but also because it provides a continuous picture of temperature distribution. 

The prognosis for patients with malignant liver tumours is poor, particularly for those with large tumours; following diagnosis, their average survival period is less than six months and, even for those with smaller tumours, estimates are that only one in four will survive beyond three years. Laser thermo-ablation, which involves destroying small tumours by applying localised heat, promises better survival rates.

Using this technique, at Frankfurt am Main University Hospital, Professor Thomas Vogl carried out tests on 80 patients. The results are impressive: 60% (compared with the usual 25%) reached a three-year survival period; around 33% survived for five years.

With twelve years’ experience in this area, Prof. Vogl now intends to use  this therapy for tumours and metastases in the lung - an area of many complications. The frequency of this disease makes the less invasive procedure particularly desirable. Bi-polar high-frequency ablation could be combined with localised chemotherapy drugs to achieve success. To confine cytostatic substances within a tumour, magnetic particles have been added to them, so that when two magnets are applied externally, the iron particles – and thus the medication – cannot migrate.
Aiming to localise prostate cancer treatment, researchers at the Institute for Diagnostic and Interventional Radiology, in Frankfurt’s Johann Wolfgang Goethe University Hospital, are developing ‘galvanotherapy’. In this method, iontophoresis (or electromotive drug administration [EMDA]) is used. A DC current applied to the prostate gland draws the drugs to the cancer site.
The disadvantage in these therapies is that any tumour that is not totally destroyed will grow again - and more quickly than is usual, resulting in frequent aftercare.

Source: Medica

14.11.2006

More on the subject:
Read all latest stories

Related articles

Photo

Article • The right tool for the task

Vascular insights with MRI and ultrasound

Advances in image post-processing and contrast-enhanced techniques have widened the scope of possibilities for MRI and ultrasound vascular imaging, experts showed in a dedicated course at the ECR…

Photo

Sponsored • Prevention, early detection, timely treatment

Fujifilm “One-Stop” solution partner for the Healthcare systems

Fujifilm aims to become an entity that can contribute to the advancement of human health by supporting the ongoing transformation in the healthcare industry – as a “One-Stop” solution partner.

Photo

Article • Radiology equipment

RADBook 2022 – Your guide to imaging technology and informatics in Europe

Our RADBook gives an overview about the most innovative diagnostic imaging systems for radiologists, cardiologists and managing directors of hospitals in Europe. The print guide is also available as…

Related products

OR Technology - dicomPACS

RIS/PACS

OR Technology - dicomPACS

OR Technology (Oehm und Rehbein GmbH)
OR Technology ORCA - OR Cloud Archive

RIS/PACS

OR Technology ORCA - OR Cloud Archive

OR Technology (Oehm und Rehbein GmbH)
allMRI GmbH – Foldable MRI wheelchair

Accessories / Complementary systems

allMRI GmbH – Foldable MRI wheelchair

allMRI GmbH
allMRI GmbH – MRI Safe Handheld Metal Detector

Accessories / Complementary Systems

allMRI GmbH – MRI Safe Handheld Metal Detector

allMRI GmbH
allMRI GmbH – MRI Waste Bin 2x 45 Liter

Accessories / Complementary Systems

allMRI GmbH – MRI Waste Bin 2x 45 Liter

allMRI GmbH
Subscribe to Newsletter